Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products

▴ Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products
This collaboration can provide a variety of NGS detection solutions

Twist Bioscience, a provider of high quality synthetic DNA through a silicon platform company, today announced a partnership with China's leading Berry Gene, a supplier of high-throughput sequencing (NGS) in China, has reached a strategic cooperation and will add Twist's NGS targeted enrichment and library preparation tools to its products, aiming to promote the high-standard development of precision medical in vitro diagnostics in China.

This product combines Berry Gene's expertise in genomics and high-throughput sequencing (NGS), as well as Twist Bioscience's large-scale manufacturing capabilities, and can provide a variety of NGS detection solutions. The combined product aims to provide researchers with high-quality tools for better application in the screening of tumours and genetic diseases.

"We are very happy to cooperate with Berry Gene, which is one of the most popular and leading companies in the gene sequencing industry in China," said Dr Emily M. Leproust, CEO and co-founder of Twist Bioscience. "Berry has extensive experience in transforming genetic testing technology into clinical applications and has achieved remarkable results. In recent years, Berry Gene has been at the forefront of using NGS to detect diseases and is committed to making more Chinese people enjoy To the health benefits of gene sequencing technology. Twist is honoured to add our NGS solution to Berry Gene’s products."

The NGS products provided by Twist are unique in that they have unparalleled uniformity and have all been quality-verified (QC). The new product will provide Berry Gene with the highest-quality NGS product portfolio today, which will further promote the high-standard development of precision medical in vitro diagnostics in China.

Berry Gene and Twist Bioscience will work closely to develop a more innovative and cutting-edge NGS product portfolio to maintain a leading position in the diagnosis and screening of genetic diseases, and provide Berry Gene with more, better and timely Research and IVD solutions.

Every oligonucleotide of Twist has been verified by NGS to ensure the accuracy of each probe sequence and the presence of all probes in the delivered probe pool, which will further improve the accuracy of our products. We are very I am glad to add Twist NGS series products to our product line. "Dr Zhou Daixing, general manager of Berry Gene said.

Tags : #TwistBioscience #LatestNewsonTwistBioscience22ndFeb #BerryGene #LatestNewsonBerryGene22ndFeb #LatestPharmaNews22ndFeb #LatestPharmaCollaboration22ndFeb #LatestNewsonGeneticDiseases #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024